{"id":46035,"date":"2022-07-11T18:02:05","date_gmt":"2022-07-11T16:02:05","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/"},"modified":"2022-07-11T18:02:05","modified_gmt":"2022-07-11T16:02:05","slug":"global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/","title":{"rendered":"Global Hunter Syndrome Treatment Market Analysis to 2026 &#8211; Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5607115\/hunter-syndrome-treatment-market-analysis-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=9x82fk&amp;utm_campaign=1724334+-+Global+Hunter+Syndrome+Treatment+Market+Analysis+to+2026+-+Focus+on+Hematopoietic+Stem+Cell+Transplant+(HSCT)+and+Enzyme+Replacement+Therapy+(ERT)&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Hunter Syndrome Treatment Market Analysis by Treatment (Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT)), and by Region &#8211; Forecast to 2026&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220711005688\/en\/1509688\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220711005688\/en\/1509688\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global hunter syndrome treatment market size is estimated to be USD 995.71 million in 2021 and is expected to witness a CAGR of 7.83% during the forecast period.\n<\/p>\n<p>\nIncrease in number of patients suffering from hunter syndrome is a key driver for the growth of the global hunter syndrome treatment market.\n<\/p>\n<p>\nAdditionally, the rise in initiatives taken up by the governments, introduction of novel therapies in the market, and occurrence of strong pipeline portfolio are some of the other drivers propelling the market growth.\n<\/p>\n<p>\nNevertheless, the increasing cost of treatment and lack of awareness about hunter syndrome treatment are expected to restrain the global market growth.\n<\/p>\n<p>\nThe hunter syndrome treatment market report is categorized into the following segments and subsegments:\n<\/p>\n<p>\n<strong>By Treatment (Revenue, USD Million, 2021-2029)<\/strong>\n<\/p>\n<ul>\n<li>\nHematopoietic Stem Cell Transplant (HSCT)\n<\/li>\n<li>\nEnzyme Replacement Therapy (ERT)\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>By Region (Revenue, USD Million, 2021-2029)<\/strong>\n<\/p>\n<p>\n<strong>North America<\/strong>\n<\/p>\n<ul>\n<li>\nU.S.\n<\/li>\n<li>\nCanada\n<\/li>\n<\/ul>\n<p>\n<strong>Europe<\/strong>\n<\/p>\n<ul>\n<li>\nGermany\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nUK\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nRussia\n<\/li>\n<li>\nRest of Europe\n<\/li>\n<\/ul>\n<p>\n<strong>Asia Pacific<\/strong>\n<\/p>\n<ul>\n<li>\nChina\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nAustralia\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nRest of APAC\n<\/li>\n<\/ul>\n<p>\n<strong>Latin America<\/strong>\n<\/p>\n<ul>\n<li>\nBrazil\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nArgentina\n<\/li>\n<li>\nRest of LATAM\n<\/li>\n<\/ul>\n<p>\n<strong>Middle East &amp; Africa<\/strong>\n<\/p>\n<ul>\n<li>\nSouth Africa\n<\/li>\n<li>\nSaudi Arabia\n<\/li>\n<li>\nRest of MEA\n<\/li>\n<\/ul>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nTakeda Pharmaceutical Company (Japan)\n<\/li>\n<li>\nGC Pharma (South Korea)\n<\/li>\n<li>\nJCR Pharmaceuticals Co Ltd. (Japan)\n<\/li>\n<li>\nRegenxBio Inc. (U.S.)\n<\/li>\n<li>\nSangamo Therapeutics Inc. (U.S.)\n<\/li>\n<li>\nArmaGen Inc. (U.S.)\n<\/li>\n<li>\nInventiva S.A. (France)\n<\/li>\n<li>\nDenali Therapeutics Inc. (U.S.)\n<\/li>\n<li>\nBioasis Technologies Inc. (Canada)\n<\/li>\n<li>\nAvrobio Inc. (U.S.)\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5607115\/hunter-syndrome-treatment-market-analysis-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=9x82fk&amp;utm_campaign=1724334+-+Global+Hunter+Syndrome+Treatment+Market+Analysis+to+2026+-+Focus+on+Hematopoietic+Stem+Cell+Transplant+(HSCT)+and+Enzyme+Replacement+Therapy+(ERT)&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/gtd8tm<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#x74;&#111;:&#x70;&#x72;&#101;s&#x73;&#x40;&#114;e&#x73;&#x65;&#97;r&#x63;&#104;&#97;n&#x64;&#109;a&#x72;&#x6b;&#101;t&#x73;&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#115;&#x73;&#64;&#x72;e&#115;&#x65;a&#x72;&#x63;&#104;&#x61;n&#100;&#x6d;a&#x72;&#x6b;&#101;&#x74;s&#46;&#x63;&#111;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hunter Syndrome Treatment Market Analysis by Treatment (Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT)), and by Region &#8211; Forecast to 2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global hunter syndrome treatment market size is estimated to be USD 995.71 million in 2021 and is expected to witness a CAGR &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46035","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Hunter Syndrome Treatment Market Analysis to 2026 - Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Hunter Syndrome Treatment Market Analysis to 2026 - Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hunter Syndrome Treatment Market Analysis by Treatment (Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT)), and by Region &#8211; Forecast to 2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global hunter syndrome treatment market size is estimated to be USD 995.71 million in 2021 and is expected to witness a CAGR ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-11T16:02:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220711005688\/en\/1509688\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Hunter Syndrome Treatment Market Analysis to 2026 &#8211; Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-11T16:02:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\\\/\"},\"wordCount\":341,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005688\\\/en\\\/1509688\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\\\/\",\"name\":\"Global Hunter Syndrome Treatment Market Analysis to 2026 - Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005688\\\/en\\\/1509688\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-11T16:02:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005688\\\/en\\\/1509688\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005688\\\/en\\\/1509688\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Hunter Syndrome Treatment Market Analysis to 2026 &#8211; Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Hunter Syndrome Treatment Market Analysis to 2026 - Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Hunter Syndrome Treatment Market Analysis to 2026 - Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hunter Syndrome Treatment Market Analysis by Treatment (Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT)), and by Region &#8211; Forecast to 2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global hunter syndrome treatment market size is estimated to be USD 995.71 million in 2021 and is expected to witness a CAGR ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-11T16:02:05+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220711005688\/en\/1509688\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Hunter Syndrome Treatment Market Analysis to 2026 &#8211; Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) &#8211; ResearchAndMarkets.com","datePublished":"2022-07-11T16:02:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/"},"wordCount":341,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220711005688\/en\/1509688\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/","name":"Global Hunter Syndrome Treatment Market Analysis to 2026 - Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220711005688\/en\/1509688\/21\/logo.jpg","datePublished":"2022-07-11T16:02:05+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220711005688\/en\/1509688\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220711005688\/en\/1509688\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-hunter-syndrome-treatment-market-analysis-to-2026-focus-on-hematopoietic-stem-cell-transplant-hsct-and-enzyme-replacement-therapy-ert-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Hunter Syndrome Treatment Market Analysis to 2026 &#8211; Focus on Hematopoietic Stem Cell Transplant (HSCT) and Enzyme Replacement Therapy (ERT) &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46035"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46035\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}